Originally reported by businesswire. Read more
Archive summary Clinical & research
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement
WALTHAM, Mass.--(BUSINESS WIRE) $CYCN--Cyclerion Therapeutics, Inc. (“Cyclerion”) (Nasdaq: CYCN) and Korsana Biosciences, Inc. (“Korsana”), a privately-held biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that t
Newsletter
The weekly digest
Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.